Aβ-Induced Synaptic Alterations Require the E3 Ubiquitin Ligase Nedd4-1

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Alzheimer's disease (AD) is characterized by progressive cognitive decline, linked to synaptic dysfunction.
• Amyloid-beta (Aβ) peptides are implicated in AD pathogenesis, causing decreased surface AMPA receptors (AMPARs), reduced synaptic strength, and altered synaptic plasticity.
• The precise molecular mechanisms underlying Aβ-induced synaptic alterations remain unclear.

Purpose of the Study:

• To investigate the role of ubiquitination in Aβ-induced synaptic dysfunction in cultured rat neurons.
• To determine if the ubiquitin ligase Nedd4-1 is involved in Aβ-mediated changes to AMPARs and synaptic function.

Main Methods:

• Cultured rat neurons were treated with Aβ to model Alzheimer's disease.
• Ubiquitination of AMPARs was assessed.
• The localization and activity of Nedd4-1 were examined in response to Aβ.
• Nedd4-1 levels were manipulated to assess its necessity for Aβ-induced synaptic changes.

Main Results:

• Aβ exposure promoted the ubiquitination of AMPARs.
• Nedd4-1, an E3 ubiquitin ligase, was recruited to synapses following Aβ treatment.
• Nedd4-1 was essential for Aβ-induced reductions in surface AMPARs, synaptic strength, and dendritic spine density.

Conclusions:

• Ubiquitination, mediated by Nedd4-1, plays a critical role in Aβ-induced synaptic dysfunction.
• Nedd4-1 facilitates the reduction of surface AMPARs and synaptic weakening in response to Aβ.
• This study highlights a novel mechanism involving Aβ-mediated control of a ubiquitin ligase in regulating synaptic function, offering potential therapeutic targets for AD.